November marks the recognition of "Movember," the month where moustaches are heralded to raise awareness and funds for men's health issues, including ...

Prostate cancer hits black men especially hard. One out of every 5 black men will be diagnosed with prostate cancer during his lifetime, and 5 out of 100 will die of the disease.

By Evelyn Lamb (Click here for the original article) Forgoing a test to detect prostate cancer could mean that three times as many men would fail ...

WASHINGTON — There's more advice on the contentious issue of prostate cancer screening: A leading group of cancer specialists says the decision ...

The dilemma for PSA screening and many other tests and treatments is that there's no science-based way to know whether holding back constitutes "rationing" for particular patients.

The serum PSA test should not be used alone for screening; it leads to too many unnecessary biopsies. A better estimate of individual risk, including the risk of more lethal disease, can be obtained by combining the PSA test with other information.

The time for a new approach for men and prostate cancer screening has now come. But you must be persistent and seek a new course.

Despite the fact that a major U.S. panel has recommended against prostate-specific antigen blood testing for prostate cancer in older men, a new study...

-- A big study of men in Europe gives mixed results about prostate cancer screening that may do little to change minds about its value. The study fi...

By Christine Gorman (Click here for the original article) The latest findings about the ineffectiveness of PSA testing to screen for prostate can...

By Genevra Pittman NEW YORK (Reuters Health) - Annual screening for prostate cancer doesn't cut men's chances of dying from the disease...

WASHINGTON -- No major medical group recommends routine PSA blood tests to check men for prostate cancer, and now a government panel is saying they do...

Still, in its aggressive form, prostate cancer is serious business: It kills 30,000 men each year in the U.S. and is the second most common cause of cancer death among men (after lung cancer).